Keros Therapeutics
(NASDAQ:KROS)
$54.27
-3.33[-5.78%]
At close: May 10
$54.27
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Wed May 8th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Keros Therapeutics Stock (NASDAQ:KROS), Quotes and News Summary

Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.

Open$58.060
Close$54.270
Volume / Avg.379.030K / 346.950K
Day Range53.590 - 58.425
52 Wk Range27.020 - 73.000
Market Cap$1.958B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
8.91%
Days to Cover9.8

Recent News

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Avi Kapoor
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following better-than-expected quarterly results.
Avi Kapoor
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Dec 23
3
Mar
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
KROS
SNDX

FAQ

Q

How do I buy Keros Therapeutics (KROS) stock?

A

You can purchase shares of Keros Therapeutics (NASDAQ: KROS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Keros Therapeutics's (KROS) competitors?

A

Other companies in Keros Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO) and Dyne Therapeutics (NASDAQ:DYN).

Q

What is the target price for Keros Therapeutics (KROS) stock?

A

The latest price target for Keros Therapeutics (NASDAQ: KROS) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 100.00 expecting KROS to rise to within 12 months (a possible 84.26% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Keros Therapeutics (KROS)?

A

The stock price for Keros Therapeutics (NASDAQ: KROS) is $54.27 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does Keros Therapeutics (KROS) pay a dividend?

A

There are no upcoming dividends for Keros Therapeutics.

Q

When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?

A

Keros Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.

Q

Is Keros Therapeutics (KROS) going to split?

A

There is no upcoming split for Keros Therapeutics.

Q

What sector and industry does Keros Therapeutics (KROS) operate in?

A

Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch